INMD vs ISRG

InMode retains significant 10x potential within 3-5 years, underpinned by its market leadership in minimally invasive aesthetic devices. The company's proprietary RF technology (e.g., Morpheus8) continues to drive brand recognition and a sticky business model with recurring consumable revenue. Financial health remains exceptionally strong (debt-free, cash-rich, consistently profitable). While macr...

Intuitive Surgical (ISRG) continues to demonstrate strong operational performance, evidenced by its Q4 2025 revenue growth of 18.8% YoY and robust EPS beat. It maintains its undisputed leadership in robotic-assisted surgery, supported by a growing installed base of 11,423 da Vinci systems and impressive Ion system adoption. The company's formidable moat, built on IP, high switching costs, and exte...